1198444
1206367
1206379
H3D Vision & Mission
Vision: To be the leading organisation for integrated drug discovery and development on the African continent Mission: Discover and develop innovative, life saving medicines For African patients Through excellence in interdisciplinary,...
H3D Facilities
Facilities H3D has state of the art laboratory equipment and access to modern instrumentation housed in the Department of Chemistry, the Department of Clinical Pharmacology and the Institute of Infectious Disease and Molecular Medicine (IDM) at UCT...
R&D Environment
UCT offers a truly integrated environment for translational research in communicable and non communicable diseases afflicting people in Africa. It has both the infrastructure as well as numerous groups working on pre-clinical and clinical research...
Home > Home

News

Thursday, 6 August 2020
Kelly Chibale, Medicine Maker Power List

If You Build It, They Will Come' - Prof Kelly Chibale features in The Medicine Maker for founding the first Drug Discovery and Development Centre (H3D) in Africa.   He was also included in the magazine's 2020 Power List. See list here:  https://themedicinemaker.com/power-list/2020

Publication Date:
Wed, 17 Jun 2020 - 07:45
Registration is now open for the H3D Symposium, 10-12 March 2021

We are pleased to advise that the H3D Symposium has been rescheduled for 10-12 March 2021, Spier Conference Centre, Stellenbosch, Cape Town.

To register or for more information, please visit the symposium website. Should you require any assistance with your existing or new registration, please do not hesitate to contact our Secretariat Office on: +27 21 9101913 / h3d@allevents.co.za

We look forward to seeing you in March 2021

Kind Regards
The Organising Committee

Publication Date:
Wed, 17 Jun 2020 - 07:45
Proposals on 2nd Drug Discovery Call is Open - Grand Challenges Africa Round 10

The African Academy of Sciences (AAS), through its Grand Challenges Africa programme, The Drug Discovery and Development Centre (H3D) at the University of Cape Town (UCT), Medicines for Malaria Venture (MMV) and the Bill and Melinda Gates Foundation (BMGF) came together in 2018 to expand and strengthen the drug discovery community in Africa. 

The first cohort of eight drug discovery scientists was successfully awarded in June 2019, after a rigorous selection process.

 

Interested to be a part of the next phase of support for the drug discovery call 2020? Please apply here through the AAS website.

Article credit: AAS. (https://www.aasciences.africa/calls/grand-challenges-africa-round-10-2nd-drug-discovery-call)
Publication Date:
Wed, 03 Jun 2020 - 07:45
Dr Lauren Arendse awarded 2020 FLAIR fellowship
Dr Lauren Arendse, H3D Scientist, was among the four young researchers from the University of Cape Town (UCT) who were selected to form part of the 2020 cohort of Future Leaders – African Independent Research (FLAIR) fellows. These fellowships are awarded to talented African early-career researchers whose work is focused on solving the needs of the continent.
Publication Date:
Mon, 11 May 2020 - 13:00

Pages